Save time and jump to the most important pieces.
4 - GAXOS.AI INC. (0001895618) (Issuer)
4 - GAXOS.AI INC. (0001895618) (Issuer)
4 - GAXOS.AI INC. (0001895618) (Issuer)
Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell. "The addition of top medical talent to our Medical Advisory Board reflects our continued commitment to pursuing a best-in-class solution for Gaxos Health," said Vadim Mats, CEO of Gaxos.AI. "An advisory board of experts in their respective fields will allow to create a better product and advancing our mission of creating value for shareholders." Dr. Eric Margolis, M.D. is a Board-Ce
Roseland, NJ, March 13, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it had acquired the rights to use certain AI-enabled technology from a top biohacking app, "Ultiself," in order to facilitate the development of its tech for Gaxos Health. The integration of Ultiself's proprietary technology into Gaxos Health's proposed product offering will enable enhanced customization and user experience aligning with modern-day consumer's demands for custom and efficient solutions. This move is expected to accelerate Gaxos Health's development and help solidify its positio
Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has finalized partnerships with premier testing laboratories.
Gaxos.ai Inc. (NASDAQ:GXAI) shares are volatile Wednesday after the company announced it has partnered with Meshy to deliver 3D assets in its AI solution for game developers and publishers. The Details: Gaxos.ai and Meshy have partnered to use generative AI to transform text and images into 3D models in Gaxos.ai’s game development solution. “We are happy to announce our partnership with Meshy to deliver quality 3D models through our product,” said Vadim Mats, CEO of Gaxos.AI. “We look forward to working with Meshy to make our product and service and integral part of any game developer’s or publisher’s toolkit.” Read Next: What Happened With Trump Media & Technology Group Stock To
Roseland, NJ, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it will participate in the upcoming Game Industry Conference on October 24th - 27th in Poznan, Poland, "We are excited to be part of GIC 2024," said Vadim Mats, CEO of Gaxos. "As we continue to engage globally with development communities, gamers, and industry leaders, we forge meaningful relationships that facilitate growth for our AI offerings." To meet with Gaxos at the conferences or for press inquiries, please email [email protected] About Game Industry Conference The Game Industry Conference
A Media Snippet accompanying this announcement is available by clicking on this link. ROSELAND, N.J., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today revealed the official launch of Gaxos Labs, its cutting-edge artificial intelligence solution for game developers and publishers. Gaxos Labs empowers game developers to accelerate the development process, enhance creativity and increase revenue through its proprietary generative AI asset editor and Unity plugin, and player-facing generative AI offering. By utilizing Gaxos Labs, developers can quickly create, refine, and ma
Roseland, NJ, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQ:GXAI), ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it has entered into a definitive agreement for the exercise of certain existing warrants to purchase an aggregate of 1,256,734 shares of its common stock originally issued in March 2024 and having an original exercise price of $5.50 per share, at a reduced exercise price of $2.58 per share. The issuance and sale of the shares of common stock issuable upon exercise of the existing warrants is registered pursuant to an effective registration statement on Form S-3 (File No. 333-278513).
EFFECT - GAXOS.AI INC. (0001895618) (Filer)
PRE 14A - GAXOS.AI INC. (0001895618) (Filer)
S-3 - GAXOS.AI INC. (0001895618) (Filer)